Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

| More on:
Broker written in white with a man drawing a yellow underline.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Aristocrat Leisure Limited (ASX: ALL)

Analysts at Morgans have retained their add rating on this gaming technology company's shares with a significantly improved price target of $67.00. The broker has increased its valuation after updating its earnings forecasts to reflect strong industry data and feedback. Morgans highlights that the company's iGaming business is outperforming expectations and believes that its digital business, Pixel United, is performing to expectations. This is a positive for investors given recent trends from this side of its business. The Aristocrat share price is trading at $62.12 on Monday.

CSL Ltd (ASX: CSL)

According to a note out of Citi, its analysts have retained their buy rating and $345.00 price target on this biotechnology company's shares. The broker highlights that rival Takeda Pharmaceutical Co Ltd (NYSE: TAK) has just released its quarterly update and revealed a strong increase in immunoglobulin products revenue over the prior corresponding period. Citi notes that this performance was in line with its expectations and believes it bodes well for CSL's performance during the first half of FY 2025. In fact, it feels that Takeda's quarter supports its view that CSL will outperform the market's expectations for immunoglobulin and albumin sales during the half. In light of this, it continues to rate CSL as a buy and sees plenty of value in its shares at current levels. The CSL share price is fetching $284.89 at the time of writing.

Nickel Industries Ltd (ASX: NIC)

A note out of Bell Potter reveals that its analysts have retained their buy rating on this nickel producer's shares with a trimmed price target of $1.43. This follows the release of Nickel Industries' quarterly update. Overall, Bell Potter believes this was a positive quarter with nickel pig iron (NPI) production down marginally on prior quarters but offset by increased production of higher margin Mixed Hydroxide Precipitate. Outside this, the broker likes Nickel Industries because it is one of the world's largest listed nickel producers and offers exposure across a range of nickel products and markets. It also notes that the company offers attractive production and margin growth in 2025, unfranked dividends, and trades on undemanding forward valuation multiples. The Nickel Industries share price is trading at 91.7 cents at the time of writing.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Guess which beaten down ASX share is rocketing 11% today

Why are investors buying this beaten down stock? Let's find out.

Read more »

Broker working with share prices on computers.
Broker Notes

These 3 ASX All Ords stocks just got sizeable broker upgrades

Top brokers expect strong performance from these ASX All Ords stocks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans says these ASX 200 stocks can rise 30%

Big returns could be on the cards for buyers of these shares.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle
Broker Notes

Here are the latest broker rating changes on 3 prominent ASX shares

Brokers have delivered a mixed bag this week.

Read more »

Two people climb to the summit and raise their arms in success as the sun rises brightly over the mountains.
Financial Shares

'Strong momentum': 2 ASX financial shares backed by top fundie for 2025

ASX financial shares had a strong trading session on Tuesday with several new price records set.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Broker Notes

The best Australian shares to buy with $7,000 right now

Analysts think these shares could give you a good return on investment.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Broker Notes

Top broker says buy ResMed and this ASX 200 share

Ord Minnett was impressed with their quarterly updates from last month.

Read more »